Natural History and Clinical Associations of Plasma Interleukin-6 Levels in Traumatic Brain Injury
Plasma Interleukin-6 and Traumatic Brain Injury Plasma interleukin-6 (IL-6) plays a pivotal role in the body’s immune response and has […]
Key genetic biomarkers and therapeutic potential in multiple sclerosis: Insights from integrated bioinformatics and mendelian randomization
Key Genetic Biomarkers Within the complex landscape of multiple sclerosis (MS), certain genetic biomarkers play a crucial role in understanding
Analysis of Interindividual Lesion Progression Variability in Adult Cerebral Adrenoleukodystrophy
Study Overview This study focuses on understanding how different individuals with adult cerebral adrenoleukodystrophy (ALD) experience variations in the progression
FCGR3A Polymorphism Controls B-Cell Repopulation Kinetics in People With Multiple Sclerosis Treated With Ocrelizumab
Study Overview This study investigates the impact of the FCGR3A gene polymorphism on the kinetics of B-cell repopulation in patients
Natalizumab and Tyruko (natalizumab biosimilar) for treating highly active relapsing-remitting multiple sclerosis after at least one disease-modifying therapy: a systematic review and economic model
Natalizumab and Tyruko in Multiple Sclerosis Therapy Natalizumab is a monoclonal antibody that targets the alpha-4 integrin subunit, inhibiting the
Subcutaneous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy
Study Overview The study focused on the use of subcutaneous immunoglobulin (SCIg) therapy for patients diagnosed with chronic inflammatory demyelinating
Cholesterol Drives IFITM3+ Microglia Activation and Induces STING Mediated Neuroinflammation After Ischemic Stroke
Study Overview The research focuses on the relationship between cholesterol levels and the activation of a specific type of immune
Refractory Form of Chronic Idiopathic Demyelinating Polyneuropathy with Rituximab Effect: A Case Report
Disease Background Chronic Idiopathic Demyelinating Polyneuropathy (CIDP) is a neurological disorder characterized by progressive weakness and impaired sensory function due
Eculizumab treatment in the salvage therapy of MOGAD: a case report
Study Overview This case report describes the use of Eculizumab, a monoclonal antibody inhibiting complement protein C5, in the treatment
Eculizumab treatment in the salvage therapy of MOGAD: a case report Read Post »
Free Epstein-Barr virus-induced gene 3 functions as an autonomous immunosuppressive cytokine to maintain immune tolerance
Study Overview The research focuses on the role of the Epstein-Barr virus (EBV) and its associated gene 3 (EBV-induced gene